3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
13
Phase 3
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
2
Other hematologic neoplasm
1
Other
1
Lymphoid
1
Endocrine
1
Conditions
Mucositis
8
Neoplasms
3
Head and Neck Neoplasms
3
Stomach Neoplasms
2
Lymphoma
2
Intestinal Obstruction
2
Gastrointestinal Stromal Tumors
2
Constipation
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Xerostomia
1
Stomatitis
1
Sexual Dysfunctions, Psychological
1
Rectal Neoplasms
1
Radiation-induced Oral Mucositis
1
Pancreatic Neoplasms
1
Obesity
1
Nutrition Disorders
1
Neurotoxicity Syndromes
1
Motor Activity
1
Lymphoma, Large B-Cell, Diffuse
1
Hypertension
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Dyspnea
1
Diabetes Mellitus
1
Depression
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Bile Duct Neoplasms
1
Interventions
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Depression
×
Other
×
Clear all
NCT03443635
2022-04-29
CHOP
Tulane University
Phase 1/2
Completed
7,192 enrolled
7 charts